Myositis associated with pembrolizumab presenting with myastheniform symptoms: two case reports

彭布罗利珠单抗 肌炎 医学 皮肤病科 内科学 癌症 免疫疗法
作者
S. Deveci,Mustafa Uzun,Pınar Özçelik,Sebile Serranur Tümer Doğukan,Zeliha Matur
出处
期刊:Anti-Cancer Drugs [Lippincott Williams & Wilkins]
被引量:1
标识
DOI:10.1097/cad.0000000000001665
摘要

Immune checkpoint inhibitors (ICIs), such as pembrolizumab, have revolutionized cancer treatment by enhancing the immune system's response to malignancies. However, these therapies are associated with immune-related adverse events (irAEs), including neuromuscular complications such as myasthenia gravis, myositis, and myocarditis. We describe two male patients, aged 67 and 68, with small cell and non-small cell lung cancers, who developed progressive neuromuscular symptoms, including ptosis, diplopia, and generalized weakness, after receiving pembrolizumab. Clinical, biochemical, imaging, and electrophysiological findings confirmed the diagnosis of myositis with myastheniform features, with one case also involving myocarditis. Both patients underwent treatments with intravenous immunoglobulin (IVIg), pyridostigmine, and corticosteroids. The first patient, despite aggressive treatment including plasma exchange and rituximab, succumbed to complications from aspiration pneumonia. The second patient showed partial response to pyridostigmine and IVIg but later died due to metastatic cancer progression. A literature review revealed 52 cases of pembrolizumab-associated myositis with myastheniform symptoms, emphasizing its high morbidity and the need for vigilant monitoring. Pembrolizumab-associated myositis with myastheniform symptoms, especially when accompanied by myocarditis, presents a significant clinical challenge with high mortality. Early recognition and aggressive management of these irAEs are crucial to improving outcomes in cancer patients receiving ICIs.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ASYHJM完成签到,获得积分10
刚刚
彭于晏的应助被朴实的小萱采纳,获得10
1秒前
邓明蕊完成签到,获得积分10
1秒前
叶辛完成签到,获得积分10
1秒前
1秒前
沫栀发布了新的文献求助10
1秒前
QDU的应助被积极努力采纳,获得10
1秒前
2秒前
2秒前
3秒前
TYH关闭了TYH的文献求助
3秒前
3秒前
跳跃靖发布了新的文献求助10
3秒前
4秒前
CipherSage的应助被朴素的士晋采纳,获得10
4秒前
molihuakai的应助被阳光雨堂采纳,获得10
4秒前
搞怪的芙发布了新的文献求助10
5秒前
慕青的应助被YH采纳,获得10
5秒前
yu完成签到,获得积分20
6秒前
6秒前
星辰大海的应助被WYL采纳,获得10
6秒前
7秒前
哈基米完成签到,获得积分10
7秒前
7秒前
8秒前
Hasson发布了新的文献求助10
8秒前
十一完成签到,获得积分10
8秒前
8秒前
drugster完成签到,获得积分10
8秒前
SciGPT的应助被heoouijee采纳,获得10
8秒前
112233完成签到,获得积分10
9秒前
桐桐的应助被香橙采纳,获得10
9秒前
所所的应助被流年采纳,获得10
9秒前
852的应助被务实的书芹采纳,获得10
9秒前
10秒前
CarryLJR发布了新的文献求助10
10秒前
研友_VZG7GZ的应助被flamez采纳,获得10
10秒前
天天快乐的应助被靓丽芙蓉采纳,获得10
10秒前
11秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175707
求助须知:如何正确求助?哪些是违规求助? 9567353
关于积分的说明 21792214
捐赠科研通 7770334
什么是DOI,文献DOI怎么找? 3431908
关于科研通互助平台的介绍 2556260
邀请新用户注册赠送积分活动 2477417